Your browser doesn't support javascript.
loading
Targeted mass spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP Kinase, and AKT signaling.
Whiteaker, Jeffrey R; Sharma, Kanika; Hoffman, Melissa A; Kuhn, Eric; Zhao, Lei; Cocco, Alexandra R; Schoenherr, Regine M; Kennedy, Jacob J; Voytovich, Ulianna; Lin, Chenwei; Fang, Bin; Bowers, Kiah; Whiteley, Gordon; Colantonio, Simona; Bocik, William; Roberts, Rhonda; Hiltke, Tara; Boja, Emily; Rodriguez, Henry; McCormick, Frank; Holderfield, Matthew; Carr, Steven A; Koomen, John M; Paulovich, Amanda G.
Afiliación
  • Whiteaker JR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Sharma K; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Hoffman MA; Proteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
  • Kuhn E; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.
  • Zhao L; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Cocco AR; Gillings School of Global Public Health, Kenan-Flagler Business School, University of North Carolina, Chapel Hill, NC 27599, USA.
  • Schoenherr RM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Kennedy JJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Voytovich U; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Lin C; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA.
  • Fang B; Proteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
  • Bowers K; Proteomics and Metabolomics Core, Department of Molecular Oncology, and Department of Tumor Biology, Moffitt Cancer Center & Research Institute, Tampa, FL 33612, USA.
  • Whiteley G; Antibody Characterization Laboratory, Leidos Biochemical Research Inc, Frederick National Laboratory for Cancer Research ATRF, Frederick, MD 21701, USA.
  • Colantonio S; Antibody Characterization Laboratory, Leidos Biochemical Research Inc, Frederick National Laboratory for Cancer Research ATRF, Frederick, MD 21701, USA.
  • Bocik W; Antibody Characterization Laboratory, Leidos Biochemical Research Inc, Frederick National Laboratory for Cancer Research ATRF, Frederick, MD 21701, USA.
  • Roberts R; Antibody Characterization Laboratory, Leidos Biochemical Research Inc, Frederick National Laboratory for Cancer Research ATRF, Frederick, MD 21701, USA.
  • Hiltke T; Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
  • Boja E; Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
  • Rodriguez H; Office of Cancer Clinical Proteomics Research, National Cancer Institute, Bethesda, MD, 20892, USA.
  • McCormick F; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Holderfield M; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA 94158, USA.
  • Carr SA; NCI RAS Initiative, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21701, USA.
  • Koomen JM; Department of Biology, Revolution Medicines, Inc., Redwood City, CA 94063, USA.
  • Paulovich AG; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142, USA.
Cell Rep Methods ; 1(3)2021 07 26.
Article en En | MEDLINE | ID: mdl-34671754
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Melanoma Límite: Humans Idioma: En Revista: Cell Rep Methods Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-akt / Melanoma Límite: Humans Idioma: En Revista: Cell Rep Methods Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos